Milford, Massachusetts site event recognizes achievements, strong performance, and growing client base since completion of ...
After reviewing Bausch & Lomb’s response to its observations, the FDA questioned whether the company is committed to ...
BioSpace takes stock of the psychedelic therapeutics space, which is once again on the cusp of its first FDA approval.
Sling Therapeutics is advancing the first late-stage oral drug for thyroid eye disease that, if approved, could compete ...
The FDA held a public forum on Monday to discuss the future of psychedelic therapeutics, followed by a meeting on Wednesday ...
Biopharma professionals are among those delaying retirement, with 52% expecting to leave the workforce later than originally ...
As AI becomes more embedded in biotech R&D, companies are competing for professionals who can bridge biology, machine ...
A growing number of biotechs are entering the market with newly launched medicines, a pattern indicative of “improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results